| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fad57abc23a66d5aafc44913546f294e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4338d82ac3c1fda25be25f07a6aeed2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e202c822e51ed393262aa4a38d233869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb00d6193d004798d183effb04c6bebb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91482ddd3a59d7d19e1de02a9c9daddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3e23273c41112835578240aabacfd5f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-51 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-538 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate |
2008-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a80c93d42a1df0e0927a1f103db349c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d0884a47519d7db33c70a71b308731
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da286bcef9f3b6c9166c1790632d6611
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6fe5d98cf2ec1226791de31efc3e635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1b75cffaf7c9f312cdf6b6f6c8d4e3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f4d64aa22cde6825e7ce828e5e55f97 |
| publicationDate |
2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010041599-A1 |
| titleOfInvention |
Compositions and methods for bone formation, bone remodeling and toxin protection |
| abstract |
The present invention identifies compounds that disrupt the interaction between anthrax proteins and LRP5/6 receptors, resulting in a reduction in anthrax toxicity. The compounds act to disrupt the intracellular transport of toxin complexes into a target cell. The present invention also provides methods for testing the effect of compounds on Wnt activity, through the use of in vitro experiments involving cells that have in at least one gene mutation involved in the Wnt pathway. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8716243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009312253-A1 |
| priorityDate |
2006-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |